Scientist (Formulation Development)
- Employer
- Regeneron Pharmaceuticals, Inc.
- Location
- Tarrytown, NY, United States
- Start date
- Oct 12, 2020
View more
- Discipline
- Science/R&D, Biotechnology
- Required Education
- Doctorate/PHD/MD
- Position Type
- Full time
- Hotbed
- Best Places to Work
Job Details
Qualified applicants will possess a PhD degree or foreign equivalent in Pharmaceutical Sciences, Biochemistry, Biomedical Engineering or a related field with the PhD research in studying protein formulation and protein stability and 1 year of relevant experience in biological drug candidate developability assessment in the biotech or pharmaceutical industry. Must possess 1 year of experience in the following: hands-on experience in protein thermodynamics and stability, protein characterization, analytical method development for protein formulation development; characterization of therapeutic protein, sources of protein instabilities as a drug, and analysis of appropriate analytical methods to monitor protein drug stability; hands-on experience and trouble-shooting ability with the following techniques: HPLC/UPLC, capillary electrophoresis, UV-vis spectroscopy, Dynamic light scattering, FT-IR for protein structure analysis, Differential scanning calorimetry (DSC), viscometer for protein formulation characterizations; HIAC, MFI, FlowCAM, RMM for studying particulates in protein formulation; and using lyophilizer to prepare freeze dry protein formulation and to develop lyophilization process.
Qualified applicants: Please mail resume to John Breese, Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road, Tarrytown, NY 10591. Please reference requisition code 20754BR when applying #LI-DNI, #GD-DNI, #IN-DNI
Company
Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye disease, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases.
Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune® which produces optimized fully-human antibodies, and ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.
Stock Symbol: REGN
Stock Exchange: NASDAQ
- Website
- https://www.regeneron.com/
- Phone
- 914-847-7000
- Location
-
Corporate Headquarters
777 Old Saw Mill River Road
Tarrytown
New York
10591
United States
Get job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.
Create alert